Medical Nutrition

Global Medical Nutrition Market to Reach US$17.5 Billion by 2030

The global market for Medical Nutrition estimated at US$13.5 Billion in the year 2024, is expected to reach US$17.5 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Proteins, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$5.3 Billion by the end of the analysis period. Growth in the Carbohydrates segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 8.2% CAGR

The Medical Nutrition market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Medical Nutrition Market – Key Trends & Drivers Summarized

Why Is Medical Nutrition Gaining Strategic Importance Across the Healthcare Continuum?

Medical nutrition refers to specialized dietary solutions designed to support individuals with disease-related malnutrition, metabolic disorders, chronic illnesses, or surgical recovery needs. Unlike general nutrition products, medical nutrition is formulated to meet specific clinical requirements—ranging from protein-energy repletion and micronutrient correction to immunonutrition and enteral feeding support. As healthcare systems increasingly recognize nutrition’s role in healing, disease progression, and quality of life, medical nutrition is emerging as an essential adjunct to pharmaceutical therapy and clinical care protocols.

Patients undergoing treatment for cancer, gastrointestinal diseases, renal failure, sepsis, or post-operative trauma often suffer from compromised absorption, altered metabolism, or elevated catabolic demand. In such cases, standard diets are inadequate, and tailored nutritional support becomes critical for survival, treatment tolerance, and recovery speed. Additionally, aging populations and the rise of non-communicable diseases such as diabetes and obesity are further increasing the prevalence of nutrition-related complications. These trends are reinforcing medical nutrition’s status as a frontline intervention in hospitals, ICUs, home care settings, and outpatient clinics.

How Are Product Formulations and Delivery Systems Evolving to Meet Clinical and Consumer Needs?

Medical nutrition products are becoming more advanced, patient-centric, and condition-specific, with improvements in palatability, digestibility, bioavailability, and administration flexibility. The industry now offers a wide variety of oral nutritional supplements (ONS), tube feeding formulas, elemental diets, disease-specific meal replacements, and modular nutrition blends. These products are fortified with targeted macronutrients (e.g., high-protein, high-calorie), functional ingredients (e.g., omega-3s, probiotics, MCTs), and clinical-grade micronutrients to support immune function, wound healing, muscle maintenance, and inflammation control.

For patients unable to consume orally, enteral and parenteral nutrition systems are evolving to provide sterile, stable, and easily administered solutions via nasogastric tubes, PEG tubes, or intravenous catheters. Innovations such as immune-enhancing nutrition (IEN), glycemia-controlled formulas, and protein-enhanced blends for sarcopenia are enabling tailored nutritional intervention across complex medical conditions. Taste-masking technologies, lactose-free and allergen-free variants, and texture-modified products are further broadening accessibility and adherence. Additionally, advancements in ready-to-drink packaging and single-serve sachets are improving product convenience for hospital, home, and ambulatory care.

Which Therapeutic Areas and Patient Populations Are Driving Demand for Medical Nutrition?

Medical nutrition demand is most pronounced in oncology, critical care, geriatrics, nephrology, pediatrics, and gastrointestinal disorders. In oncology, nutritional support helps patients maintain muscle mass, tolerate chemotherapy, and reduce treatment interruptions. ICU patients with sepsis, trauma, or ventilator dependence require early enteral nutrition to reduce mortality, infection risk, and hospital stay durations. Geriatric patients often suffer from age-related muscle wasting (sarcopenia), dysphagia, and micronutrient deficiencies that benefit from high-protein, texture-modified medical nutrition solutions.

In pediatrics, children with genetic metabolic disorders (e.g., PKU), cystic fibrosis, or malabsorption syndromes rely on specialized formulas that support cognitive development and prevent complications. Meanwhile, diabetic patients use glycemia-targeted nutrition to control blood sugar and minimize complications. Preoperative and postoperative nutrition is also being standardized in enhanced recovery after surgery (ERAS) protocols to improve surgical outcomes. As home-based care, long-term care facilities, and telehealth expand, medical nutrition is increasingly being integrated into disease management pathways and bundled reimbursement schemes globally.

What Is Fueling Long-Term Growth and Innovation in the Medical Nutrition Market?

The growth in the global medical nutrition market is driven by rising clinical awareness, the aging demographic trend, expanding hospital infrastructure, and regulatory support for nutrition-based therapy. As more hospitals adopt nutrition risk screening tools (e.g., MUST, NRS-2002), earlier and more frequent nutritional interventions are becoming the standard of care. Public health systems are recognizing the cost-effectiveness of medical nutrition in reducing hospital readmissions, accelerating recovery, and improving treatment adherence—leading to increased coverage under reimbursement programs in Europe, North America, and parts of Asia.

Product innovation is accelerating through partnerships between nutrition science companies, academic researchers, and clinical institutions. Companies are developing microbiome-targeted formulas, nutrigenomics-driven personalization tools, and high-density formulations for volume-restricted patients. Furthermore, digital health integration—such as remote dietitian consultations, mobile nutrition tracking, and AI-guided dietary planning—is enhancing patient engagement and monitoring.

Policy initiatives such as malnutrition awareness campaigns, parenteral nutrition guidelines, and pediatric nutrition subsidy programs are further catalyzing adoption. As the role of nutrition in preventive care, therapeutic support, and chronic disease management becomes more pronounced, medical nutrition will continue to evolve as a high-impact, evidence-based pillar of modern healthcare systems worldwide.

SCOPE OF STUDY:

The report analyzes the Medical Nutrition market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, Other Nutrition Types); Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, Other Indications); Patient Type (Infant Nutrition, Adult Nutrition, Geriatric Nutrition); Administration Route (Oral, Enteral, Parenteral); End-User (Hospitals, Home Care Settings, Long Term Care, Ambulatory Surgery Centers)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Abbott Laboratories
• Ajinomoto Co., Inc.
• AYMES International Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Cambrooke Therapeutics, Inc.
• Danone S.A.
• DSM-Firmenich
• Fresenius Kabi AG
• Glanbia plc
• Herbalife Nutrition Ltd.
• Lonza Group AG
• Mead Johnson Nutrition
• Medifood GmbH
• Medtrition, Inc.
• Nestlé Health Science
• Perrigo Company plc
• Pfizer Inc.
• Reckitt Benckiser Group plc
• Solace Nutrition, Inc.

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.